Hyaluronan, CD44, and Cyclooxygenase-2 in Colon Cancer

REFERENCES

• Pai R., Nakamura T., Moon W.S., Tarnawski A.S. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J. 2003; 17: 1640–1647
   PubMed Web of Science ®Google Scholar
• Wong N.A., Pignatelli M. Beta—catenin–a linchpin in colorectal carcinogenesis?. Am. J. Pathol. 2002; 160: 389–401
   PubMed Web of Science ®Google Scholar
• Bissell M.J. Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland. Biochem. Soc. Trans. 2007; 35: 18–22
   PubMed Web of Science ®Google Scholar
• Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Laurent T.C., Fraser J.R. Hyaluronan. FASEB J 1992; 6: 2397–2404
   PubMed Web of Science ®Google Scholar
• Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004; 4: 528–539
   PubMed Web of Science ®Google Scholar
• Hascall V.C., Majors A.K., De La Motte C.A., Evanko S.P., Wang A., Drazba J.A., et al. Intracellular hyaluronan: a new frontier for inflammation?. Biochim. Biophys. Acta. 2004; 1673: 3–12
   PubMed Web of Science ®Google Scholar
• Itano N., Sawai T., Atsumi F., Miyaishi O., Taniguchi S., Kannagi R., et al. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J. Biol. Chem. 2004; 279: 18679–18687
   PubMed Web of Science ®Google Scholar
• Markwald R.R., Fitzharris T.P., Bank H., Bernanke D.H. Structural analyses on the matrical organization of glycosaminoglycans in developing endocardial cushions. Dev. Biol. 1978; 62: 292–316
   PubMed Web of Science ®Google Scholar
• Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A. Jr., et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 2000; 106: 349–360
   PubMed Web of Science ®Google Scholar
• Anttila M.A., Tammi R.H., Tammi M.I., Syrjanen K.J., Saarikoski S.V., Kosma V.M. High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res. 2000; 60: 150–155
   PubMed Web of Science ®Google Scholar
• Ropponen K., Tammi M., Parkkinen J., Eskelinen M., Tammi R., Lipponen P., et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res. 1998; 58: 342–347
   PubMed Web of Science ®Google Scholar
• Kosunen A., Ropponen K., Kellokoski J., Pukkila M., Virtaniemi J., Valtonen H., et al. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol 2004; 40: 257–263
   PubMed Web of Science ®Google Scholar
• Wang C., Tammi M., Guo H., Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am. J. Pathol. 1996; 148: 1861–1869
   PubMed Web of Science ®Google Scholar
• Kim H.R., Wheeler M.A., Wilson C.M., Iida J., Eng D., Simpson M.A., et al. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res. 2004; 64: 4569–4576
   PubMed Web of Science ®Google Scholar
• Ropponen K.M., Eskelinen M.J., Lipponen P.K., Alhava E., Kosma V.M. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand. J. Gastroenterol. 1998; 33: 301–309
   PubMed Web of Science ®Google Scholar
• Choi S.H., Takahashi K., Eto H., Yoon S.S., Tanabe K.K. CD44s expression in human colon carcinomas influences growth of liver metastases. Int. J. Cancer. 2000; 85: 523–526
   PubMed Web of Science ®Google Scholar
• Ghatak S., Misra S., Toole B.P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J. Biol. Chem. 2005; 280: 8875–8883
   PubMed Web of Science ®Google Scholar
• Misra S., Toole B.P., Ghatak S. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J. Biol. Chem. 2006; 281: 34936–34941
   PubMed Web of Science ®Google Scholar
• Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer. 2001; 1: 11–21
   PubMed Web of Science ®Google Scholar
• Dohadwala M., Luo J., Zhu L., Lin Y., Dougherty G.J., Sharma S., et al. Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44. J. Biol. Chem. 2001; 276: 20809–20812
   PubMed Web of Science ®Google Scholar
• Ghatak S., Misra S., Toole B.P. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J. Biol. Chem. 2002; 277: 38013–38020
   PubMed Web of Science ®Google Scholar
• Dale T.C. Signal transduction by the Wnt family of ligands. Biochem. J. 1998; 329(Pt 2)209–223
   PubMedGoogle Scholar
• Castellone M.D., Teramoto H., Gutkind J.S. Cyclooxygenase-2 and colorectal cancer chemoprevention: the beta-catenin connection. Cancer Res. 2006; 66: 11085–11088
   PubMed Web of Science ®Google Scholar
• Kim H., Yang X.L., Rosada C., Hamilton S.R., August J.T. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys. 1994; 310: 504–507
   PubMed Web of Science ®Google Scholar
• Takahashi K., Stamenkovic I., Cutler M., Saya H., Tanabe K.K. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 1995; 11: 2223–2232
   PubMed Web of Science ®Google Scholar
• Misra S., Ghatak S., Toole B.P. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J. Biol. Chem. 2005; 280: 20310–20315
   PubMed Web of Science ®Google Scholar
• Bourguignon L.Y., Zhu H., Zhou B., Diedrich F., Singleton P.A., Hung M.C. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J. Biol. Chem. 2001; 276: 48679–48692
   PubMed Web of Science ®Google Scholar
• Li L., Heldin C.H., Heldin P. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. J. Biol. Chem. 2006; 281: 26512–26519
   PubMed Web of Science ®Google Scholar